Regencell Bioscience Holdings (Regencell Bioscience Holdings) Current Deferred Taxes Liabilities

: $0.00 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Regencell Bioscience Holdings's current deferred tax liabilities for the quarter that ended in Jun. 2023 was $0.00 Mil.

Regencell Bioscience Holdings Current Deferred Taxes Liabilities Historical Data

The historical data trend for Regencell Bioscience Holdings's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Current Deferred Taxes Liabilities

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial				-	-	-	-	-

Regencell Bioscience Holdings Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.